Multidonor FMT capsules improve symptoms and decrease fecal calprotectin in ulcerative colitis patients while treated – an open-label pilot study

Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis

(2019) Samuel P. Costello et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study

(2018) Sofie Ingdam Halkjær et al.   GUT

Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: A systematic review and meta-analysis

(2018) Gianluca Ianiro et al.   United European Gastroenterology Journal

Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction

(2018) Youlian Zhou et al.   mSystems

Case series of successful treatment with fecal microbiota transplant (FMT) oral capsules mixed from multiple donors even in patients previously treated with FMT enemas for recurrent Clostridium difficile infection

(2018) Mahtab Chehri et al.   MEDICINE

Alterations in the Abundance and Co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the Colonic Mucosa of Inflammatory Bowel Disease Subjects

(2018) Mireia Lopez-Siles et al.   Frontiers in Cellular and Infection Microbiology

Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Lose Dose

(2018) Jessica R. Allegretti et al.   DIGESTIVE DISEASES AND SCIENCES

European consensus conference on faecal microbiota transplantation in clinical practice

(2017) Giovanni Cammarota et al.   GUT

Exact sequence variants should replace operational taxonomic units in marker-gene data analysis

(2017) Benjamin J Callahan et al.   ISME Journal

Effect of Oral Capsule– vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection

(2017) Dina Kao et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial

(2017) Sudarshan Paramsothy et al.   LANCET

Ulcerative colitis

(2017) Ryan Ungaro et al.   LANCET

Influence of gut microbiota on neuropsychiatric disorders

(2017) María Carmen Cenit et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Rhea: a transparent and modular R pipeline for microbial profiling based on 16S rRNA gene amplicons

(2017) Ilias Lagkouvardos et al.   PeerJ

Gut microbiota dysbiosis contributes to the development of hypertension

(2017) Jing Li et al.   Microbiome

Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease

(2016) J. Schulberg et al.   INTERNAL MEDICINE JOURNAL

Adverse events in faecal microbiota transplant: a review of the literature

(2016) M. Baxter et al.   JOURNAL OF HOSPITAL INFECTION

Gasification biochar has limited effects on functional and structural diversity of soil microbial communities in a temperate agroecosystem

(2016) Valentina Imparato et al.   SOIL BIOLOGY & BIOCHEMISTRY

Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls

(2016) Jun Chen et al.   Scientific Reports

Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial

(2015) Paul Moayyedi et al.   GASTROENTEROLOGY

Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis

(2015) Noortje G. Rossen et al.   GASTROENTEROLOGY

A decrease of the butyrate-producing speciesRoseburia hominisandFaecalibacterium prausnitziidefines dysbiosis in patients with ulcerative colitis

(2013) Kathleen Machiels et al.   GUT

Phylogenetic Analysis of Dysbiosis in Ulcerative Colitis During Remission

(2013) Mirjana Rajilić-Stojanović et al.   INFLAMMATORY BOWEL DISEASES